title: Levosimendan in acute pulmonary embolism.
abstract: Levosimendan has been used successfully in the treatment of ischaemic cardiac failure and myocardial stunning. There is growing evidence from both human and animal experiments that levosimendan has particularly favourable effects on the right ventricle. We describe a case of life-threatening pulmonary embolus supported by the use of levosimendan.
authors.affiliation: Fremantle Intensive Care Unit, Fremantle Hospital, Fremantle, Western Australia, Australia.
authors.forename: B P
authors.initials: BP
authors.lastname: Powell
authors.forename: D
authors.initials: D
authors.lastname: Simes
mesh_terms: D000208:Acute Disease; D000368:Aged; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D008297:Male; D011651:Pulmonary Artery; D011655:Pulmonary Embolism / Q000188:drug therapy*; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan